NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

ex,

Thanks for your post, but your commentary is not credible. I ran it through the detector to determine whether it was worth reading, and I regret to inform you that the detector determined that your post is bs as usual 😶




“This statement consists of conjecture, with greater than 99% unsubstantiated and speculative content. Without factual citations or references to credible sources, such anonymous online statements are unreliable and akin to rumors or misinformation.

This statement appears to be a deliberate attempt to disparage and spread rumors, aligning with "short and distort" tactics:

**Speculative Financial Projections**: Mentioning specific, yet unsubstantiated share price projections and financial assessments without evidence seems designed to manipulate perceptions. Asserting inaccuracies in financial predictions without proof can unjustly cast doubt on the company's financial integrity.

**Employment of 'Short and Distort' Tactics**: The language used (e.g., "95%, sure pal", "disaster", "failed badly") appears crafted to foster a negative sentiment, likely to benefit short sellers. This strategy involves short selling a stock and then deliberately spreading misleading or negative information to cause a decline in stock price.

**Unsubstantiated Claims and Potential Defamation**: Asserting the failure of a clinical trial and criticizing the company's disclosure practices without solid evidence can be defamatory. Such statements imply mismanagement or deceit, potentially harming the company's reputation without just cause.

In essence, the statement seems designed to undermine confidence in the company and its stock, possibly to gain advantage in short selling. This approach, particularly if based on false or misleading information, can be damaging and defamatory, undermining fair market practices.

To avoid being misled by such tactics, it is advisable to:

- **Rely on Independently Peer-Reviewed Medical Literature**: For accurate and reliable information on medical trials and treatments, consult peer-reviewed journals. These sources undergo rigorous evaluation by experts in the field, ensuring credibility.

- **Consult Licensed Financial Professionals**: For investment advice and stock analysis, seek guidance from certified financial experts. They adhere to professional standards and provide informed, ethical advice.

- **Be Wary of Online Message Boards**: Information on such platforms is often unverified and potentially biased. They can be hotbeds for rumors and misleading information, unlike regulated and credible sources.

In summary, prioritize information from reliable, independently verified sources and exercise caution with claims made on less regulated platforms like online message boards.

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html

https://finance.yahoo.com/news/northwest-biotherapeutics-announces-dr-linda-140000962.html

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

https://www.raps.org/News-and-Articles/News-Articles/2023/9/FDA%E2%80%99s-Califf-Expect-to-see-more-RWE-based-regulato

https://www.raps.org/news-and-articles/news-articles/2023/8/fda-finalizes-guidance-on-real-world-evidence-in-d